Newsfeeds - Spark Newswire

1 minute read

eMagin Q2 EPS $0.00 Beats $(0.03) Est., Sales $6.30M Miss $7.70M Estimate

Today, 10:34 AM

eMagin (AMEX:EMAN) reported quarterly sales of $6.30 million which missed the analyst consensus estimate of $7.70 million by 18.18 percent. This is a 18.18 percent decrease over sales of $7.70 million the same period

EMAN

15 minute read

Earnings Scheduled For August 12, 2021

By Benzinga Insights

Today, 10:34 AM

Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.

AACG

1 minute read

Legal
News

EMagin Granted U.S. Patent Titled ‘Direct-deposition system including standoffs for controlling substrate-mask separation’

By Benzinga Newsdesk

Today, 10:34 AM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5226&f=G&l=50&d=PTXT&p=105&S1=20210615&OS=20210615&RS=20210615

EMAN

4 minute read

44 Biggest Movers From Friday

By Lisa Levin

Today, 10:34 AM

Gainers

ADAG

14 minute read

Uncategorized

Earnings Scheduled For May 13, 2021

By Benzinga Insights

Today, 10:34 AM

Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.

AACG

Latest news

eMagin Q2 EPS $0.00 Beats $(0.03) Est., Sales $6.30M Miss $7.70M Estimate

Earnings Scheduled For August 12, 2021

EMagin Granted U.S. Patent Titled ‘Direct-deposition system including standoffs for controlling substrate-mask separation’

44 Biggest Movers From Friday

Earnings Scheduled For May 13, 2021